StockData
Lipocine Inc. logo

Lipocine Inc. (LPCN) stock

LPCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3039% below fair value
$1.60−0.06 (-3.61%)

Close on Nov 17, 2026Market cap $13.19MP/E –Yield –

Lipocine market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Lipocine's market cap was $13.11M on Nov 11, 2026, against $18.65M a year earlier. Over the last 5 years it ranged from $11.87M to $120.97M, with a median of $24.28M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$13.11M-69.9%
2025Dec 31, 2025$43.52M+66.8%
2024Dec 31, 2024$26.10M+76.0%
2023Dec 29, 2023$14.83M-57.9%
2022Dec 30, 2022$35.21M-59.8%
2021Dec 31, 2021$87.51M-2.0%
2020Dec 31, 2020$89.34M+827.3%
2019Dec 31, 2019$9.63M-65.3%
2018Dec 31, 2018$27.74M-61.9%
2017Dec 29, 2017$72.86M+8.5%
2016Dec 30, 2016$67.18M-71.5%
2015Dec 31, 2015$235.89M+250.9%
2014Dec 31, 2014$67.22M-25.6%
2013Dec 31, 2013$90.36M–

More Lipocine figures

See a number that looks wrong?